Urinary cytology for the detection of urothelial carcinoma of the bladder-a flawed adjunct to cystoscopy?

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 3, 2013, Pages 366-371

  Bolenz, Christian ^a,b   West, Ann Marie ^a   Ortiz, Nicolas ^a   Kabbani, Wareef ^a   Lotan, Yair ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Bladder cancer; Cytology; Diagnostic use; Marker; Urinary bladder neoplasms; Urine

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; BLADDER IRRIGATION; BLADDER TUMOR; CANCER STAGING; CARCINOMA IN SITU; CYSTOSCOPY; EXPERIENCE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PATHOLOGIST; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; URINE CYTOLOGY; UROTHELIAL CARCINOMA OF THE BLADDER;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CYSTOSCOPY; CYTODIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATHOLOGY, CLINICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER; URINARY BLADDER NEOPLASMS; YOUNG ADULT;

EID: 84875378419     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.01.017     Document Type: Article

References (21)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2008. CA Cancer J Clin 2008, 58:71-96.
2. Nabi G., Greene D.R., O'Donnell M. How important is urinary cytology in the diagnosis of urological malignancies?. Eur Urol 2003, 43:632-636.
3. Paez A., Coba J.M., Murillo N., et al. Reliability of the routine cytological diagnosis in bladder cancer. Eur Urol 1999, 35:228-232.
4. Raitanen M.P., Aine R., Rintala E., et al. Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis. Eur Urol 2002, 41:284-289.
5. Sherman A.B., Koss L.G., Adams S.E. Interobserver and intraobserver differences in the diagnosis of urothelial cells. Comparison with classification by computer. Anal Quant Cytol 1984, 6:112-120.
6. van Rhijn B.W., van der Poel H.G., van der Kwast T.H. Urine markers for bladder cancer surveillance: A systematic review. Eur Urol 2005, 47:736-748.
7. Talwar R., Sinha T., Karan S.C., et al. Voided urinary cytology in bladder cancer: Is it time to review the indications?. Urology 2007, 70:267-271.
8. Halling K.C., King W., Sokolova I.A., et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000, 164:1768-1775.
9. Chahal R., Gogoi N.K., Sundaram S.K. Is it necessary to perform urine cytology in screening patients with haematuria?. Eur Urol 2001, 39:283-286.
10. Viswanath S., Zelhof B., Ho E., et al. Is routine urine cytology useful in the haematuria clinic?. Ann R Coll Surg Engl 2008, 90:153-155.
11. Shariat S.F., Karam J.A., Lotan Y., et al. Critical evaluation of urinary markers for bladder cancer detection and monitoring. Rev Urol 2008, 10:120-135.
12. Vrooman O.P., Witjes J.A. Urinary markers in bladder cancer. Eur Urol 2008, 53:909-916.
13. Sarosdy M.F., Kahn P.R., Ziffer M.D., et al. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol 2006, 176:44-47.
14. Lotan Y., Roehrborn C.G. Sensitivity and specificity of commonly available bladder tumor markers versus cytology: Results of a comprehensive literature review and meta-analyses. Urology 2003, 61:109-118. Discussion 118.
15. Shariat S.F., Zippe C., Ludecke G., et al. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1, or CIS transitional cell carcinoma of the bladder. J Urol 2005, 173:1518-1525.
16. Karakiewicz P.I., Benayoun S., Zippe C., et al. Institutional variability in the accuracy of urinary cytology for predicting recurrence of transitional cell carcinoma of the bladder. BJU Int 2006, 97:997-1001.
17. Raab S.S., Slagel D.D., Jensen C.S., et al. Low-grade transitional cell carcinoma of the urinary bladder: Application of select cytologic criteria to improve diagnostic accuracy [corrected]. Mod Pathol 1996, 9:225-232.
18. Wiener H.G., Vooijs G.P., van't Hof-Grootenboer B. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 1993, 37:163-169.
19. Lotan Y., Capitanio U., Shariat S.F., et al. Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection. BJU Int 2009, 103:1368-1374.
20. Murphy W.M. Current status of urinary cytology in the evaluation of bladder neoplasms. Hum Pathol 1990, 21:886-896.
21. Malik S.N., Murphy W.M. Monitoring patients for bladder neoplasms: What can be expected of urinary cytology consultations in clinical practice. Urology 1999, 54:62-66.